FGI Industries Ltd. — Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022, compared with fiscal 2021. This is an annual filing; it does not provide a clear standalone fourth-quarter results summary. Financial statement amounts are in U.S. dollars.
Business context
FGI supplies bath and kitchen products, including sanitaryware, bath furniture, shower systems and custom kitchen cabinetry. Products are sold mainly for repair and remodeling through large retailers, wholesalers, commercial distributors and e-commerce channels. The company became a standalone public company after its January 2022 reorganization and IPO; historical statements include allocated costs and may not represent the costs of an independent business.
Financial results and liquidity
| Metric | FY 2022 | FY 2021 | Change |
|---|---|---|---|
| Revenue | $161.7 million | $181.9 million | Down 11.1% |
| Gross profit | $31.5 million | $32.2 million | Down 2.2% |
| Gross margin | 19.5% | 17.7% | Up 180 basis points |
| Operating income | $5.1 million | $7.7 million | Down 34.1% |
| Operating margin | 3.1% | 4.2% | Down 110 basis points |
| Net income | $3.7 million | $7.9 million | Down 53.5% |
| Basic and diluted EPS | $0.39 | $1.13 | Lower year over year |
| Operating cash flow | $1.0 million provided | $3.2 million used | Improved |
| Capital expenditures | $1.1 million | $0.1 million | Higher |
Adjusted income from operations was $5.7 million and adjusted net income was $4.2 million in 2022; these are non-GAAP measures. At year-end, cash was $10.1 million, working capital was $16.1 million, and total current liabilities were $29.8 million. Short-term bank borrowings were $9.8 million, down from $14.7 million. The East West Bank facility has an $18 million maximum borrowing amount, is secured by FGI assets, and had a 7.25% interest rate at year-end. FGI reported compliance with its financial covenant at December 31, 2022. Lease liabilities totaled $9.4 million.
Material changes versus 2021
- Bath furniture revenue fell 46.5% to $29.5 million, reflecting channel inventory correction and softer demand.
- Sanitaryware revenue was nearly flat at $104.8 million; shower systems rose 12.9% to $21.6 million; Other revenue rose 80.7% to $5.8 million.
- Revenue declined in the United States, Canada and Europe. Canada fell 18.6% to $41.0 million.
- Gross margin improved despite lower sales, supported by pricing, product mix and lower freight costs. Selling and distribution expense was broadly flat, while G&A rose 26.4%, including public-company costs and a one-time IPO-related bonus.
- Other income declined from $1.1 million to a net expense of $0.6 million, partly because 2021 included $1.68 million of PPP loan forgiveness income.
- Cash increased from $3.9 million, supported chiefly by $12.4 million of net IPO proceeds and working-capital movements. Accounts receivable and inventory declined, while accounts payable also fell materially.
Outlook, risks and unusual items
- Management said bath furniture demand remained below historical levels into 2023, but expected a pickup in the second half of 2023. It cited margin expansion in the second half of 2022 and expects its pricing, mix and freight-related benefits to continue. No quantified revenue or earnings guidance is provided.
- The stated long-term strategy is to grow owned brands, add products and channels, and pursue selective acquisitions. Management targets mid-to-high-single-digit long-term organic revenue growth and uses a 20%+ expected return-on-capital hurdle for most material internal investments; these are strategic aims, not near-term guidance.
- Huida, a major China-based sanitaryware supplier, accounted for 51.8% of 2022 purchases and 85.5% of year-end accounts payable. An arbitrator ruled in September 2022 that the long-standing cooperation agreement was terminable; the company intends to negotiate a replacement, with no assurance of agreement. Huida remains a supplier.
- Customer concentration is significant: the top ten customers represented over 76% of 2022 sales, and two customers each represented about 22%. The Home Depot represented approximately 22.2% of sales.
- Management concluded that disclosure controls and internal control over financial reporting were ineffective at year-end due to material weaknesses involving IT controls and policies, process and risk-control documentation, and segregation of duties. Management planned remediation during 2023. The auditor gave an unqualified opinion on the financial statements but did not attest to internal-control effectiveness.
- The filing identifies economic and housing-market weakness, inflation and interest rates, foreign exchange, China-related supply and regulatory risks, cybersecurity, and dependence on Foremost and third-party manufacturers as risks. Foremost holds approximately 72% of voting power.
- The East West Bank may call its line if an outstanding corporate annual-statement reporting requirement is not met; the filing says FGI was seeking an extension. Management nevertheless judged liquidity sufficient for the next 12 months.
- FGI USA’s Ayers Bath litigation concerns recovery of a previously allowed claim of at least $5.3 million; the bankruptcy distribution was only $7,757, and the District Court process remained ongoing. The filing says the company did not believe legal claims would have a material adverse effect based on information then available.
Important facts for investors to verify
- Whether FGI reached a new supply agreement with Huida and how it is reducing supplier concentration risk.
- Whether the East West Bank reporting extension was obtained and whether the company continued to meet loan covenants and liquidity needs.
- Whether management remediated the disclosed internal-control material weaknesses and whether subsequent filings report any restatement or control changes.
- Whether bath furniture demand recovered as expected in the second half of 2023, and whether gross-margin gains persisted.
- How customer concentration, related-party sourcing and services, and Foremost’s control affect pricing, operations and capital allocation.
- Updates to the Ayers Bath matter and any other litigation, contingencies or material supplier disruptions.